Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 as Monotherapy and in Combination With Pembrolizumab in Subjects With Solid Tumors or Lymphoma

NCT03556228 is registered in ClinicalTrials.gov with VM Oncology, LLC as lead sponsor.

NCT NCT03556228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03556228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 as Monotherapy and in Combination With Pembrolizumab in Subjects With Solid Tumors or Lymphoma
Lead sponsor
VM Oncology, LLC
Phase
Phase 1/2
Overall status
Recruiting
Start date
June 8, 2018
Completion date
June 30, 2028
Enrollment
242 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

adenoid cystic carcinoma, any solid tumors progressed after a prior immunotherapy, esophageal cancer, head and neck cancers, head and neck cancers - nasopharyngeal, head and neck cancers - salivary gland, head and neck cancers - throat, head and neck cancers - tonsils, head and neck cancers hypopharynx, head and neck cancers larynx, head and neck cancers lip, head and neck cancers nasopharynx, head and neck cancers oral cavity, head and neck cancers oropharynx, head and neck cancers trachea, head and neck carcinoma, head and neck squamous cell carcinoma, head and neck squamous cell carcinoma hnscc, lung cancer, lung cancer (locally advanced or metastatic), mesothelioma, non-small cell lung cancer, pancreatic cancer, salivary gland carcinomas, small cell lung cancer ( sclc )